Fibroblast-specific TGF-β–Smad2/3 signaling underlies cardiac fibrosis
Open accessThe DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Abstract
The master cytokine TGF-β mediates tissue fibrosis associated with inflammation and tissue injury. TGF-β induces fibroblast activation and differentiation into myofibroblasts that secrete extracellular matrix proteins. Canonical TGF-β signaling mobilizes Smad2 and Smad3 transcription factors that control fibrosis by promoting gene expression. However, the importance of TGF-β-Smad2/3 signaling in fibroblast-mediated cardiac fibrosis has not been directly evaluated in vivo. Here, we examined pressure overload-induced cardiac fibrosis in fibroblast- and myofibroblast-specific inducible Cre-expressing mouse lines with selective deletion of the TGF-β receptors Tgfbr1/2, Smad2, or Smad3. Fibroblast-specific deletion of Tgfbr1/2 or Smad3, but not Smad2, markedly reduced the pressure overload-induced fibrotic response as well as fibrosis mediated by a heart-specific, latency-resistant TGF-β mutant transgene. Interestingly, cardiac fibroblast-specific deletion of Tgfbr1/2, but not Smad2/3, attenuated the cardiac hypertrophic response to pressure overload stimulation. Mechanistically, loss of Smad2/3 from tissue-resident fibroblasts attenuated injury-induced cellular expansion within the heart and the expression of fibrosis-mediating genes. Deletion of Smad2/3 or Tgfbr1/2 from cardiac fibroblasts similarly inhibited the gene program for fibrosis and extracellular matrix remodeling, although deletion of Tgfbr1/2 uniquely altered expression of an array of regulatory genes involved in cardiomyocyte homeostasis and disease compensation. These findings implicate TGF-β-Smad2/3 signaling in activated tissue-resident cardiac fibroblasts as principal mediators of the fibrotic response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Overexpression of SMAD3 enhances, whereas knockdown inhibits αSMA and extracellular matrix production in fibroblasts (45–48). Furthermore, fibroblast-specific deletion of SMAD3 reduces αSMA production and myofibroblast phenotype (49–52), for example, loss of SMAD3 lowers the number of activated myofibroblasts in cardiac fibrosis in vivo and reduces extracellular matrix production by myofibroblasts”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [47]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“By contrast, cultured human primary cardiac and dermal fibroblasts and immortalized cardiac fibroblasts were relatively poor models of human cardiac fibroblast diversity under resting or stimulated (TGFβ (refs. 19,39,40), IL-1β (ref. 41)) conditions.”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [39]
The cited source says what the claim attributes to it.
In the citing paper
“TGF-β1 activates SMAD2/3 signaling, driving pro-fibrotic gene expression and extracellular matrix deposition in cardiac fibroblasts [85].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [85]
The cited source says what the claim attributes to it.
In the citing paper
“In contrast, primary human cardiac fibroblasts, primary human dermal fibroblasts, and immortalized human cardiac fibroblasts were relatively poor models of human cardiac fibroblast diversity under resting or stimulated (TGFβ 20,33,34 , IL-1 β 35 ) conditions.”
From Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure (2022) · cites this paper as [33]
The cited source says what the claim attributes to it.
In the citing paper
“While numerous studies have implicated a role for TGFβ signaling in maladaptive cardiac remodeling and scar formation in HF 20,33”
From Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure (2022) · cites this paper as [33]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591 · cited 1×
“Heart failure is an increasingly prevalent disease characterized by reduced cardiac output resulting from a progressive loss of cardiomyocytes, ventricular chamber remodeling, and accumulation of interstitial fibrosis (1).”
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,373
Nagueh, S. F., Smiseth, O. A., Appleton, C. P., Byrd, B. F., Dokainish, H., Edvardsen, T., Flachskampf, F. A., Gillebert, T. C., Klein, A. L., Lancellotti, P., et al. (2016) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2016.01.011 · Cited by 5,262
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
TGF-β: the master regulator of fibrosis
Meng, X.-M., Nikolic-Paterson, D. J., & Lan, H. Y. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.48 · Cited by 3,528 · cited 1×
“Global TGF-β activity is upregulated in diseased hearts, where one of its primary actions is directed at the resident fibroblasts to alter the fibrotic response and ventricular remodeling (47, 48).”
Nagueh, S. F., Smiseth, O. A., Appleton, C. P., Byrd, B. F., Dokainish, H., Edvardsen, T., Flachskampf, F. A., Gillebert, T. C., Klein, A. L., Lancellotti, P., et al. (2016) · European Heart Journal – Cardiovascular Imaging · doi:10.1093/ehjci/jew082 · Cited by 2,425 · cited 1×
“The ratio of these measures ( E/e ′ ) was used as an indicator of diastolic function (60).”
Cardiac Fibroblast: The Renaissance Cell
Souders, C. A., Bowers, S. L. K., & Baudino, T. A. (2009) · Circulation Research · doi:10.1161/circresaha.109.209809 · Cited by 984 · cited 1×
“Progressive cardiac fibrosis in heart failure is predominantly mediated by the tissue-resident cardiac fibroblast, which becomes activated and then differentiated into a cell type referred to as the myofibroblast (5, 6).”
Transforming growth factor (TGF)-β signaling in cardiac remodeling
Dobaczewski, M., Chen, W., & Frangogiannis, N. G. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.033 · Cited by 934 · cited 1×
“TGF-β is considered a “master” cytokine/growth factor produced within injured or diseased tissues, where it activates fibroblasts and facilitates ECM production (15, 16).”
The role of TGF-β signaling in myocardial infarction and cardiac remodeling
BUJAK, M., & FRANGOGIANNIS, N. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.10.002 · Cited by 927
Genetic lineage tracing defines myofibroblast origin and function in the injured heart
Kanisicak, O., Khalil, H., Ivey, M. J., Karch, J., Maliken, B. D., Correll, R. N., Brody, M. J., J. Lin, S.-C., Aronow, B. J., Tallquist, M. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12260 · Cited by 892 · cited 6×
“Hence, here we used mice in which the Postn genetic locus was targeted with a tamoxifen-inducible MerCreMer (MCM) cDNA (29), and these mice were crossed with Smad2 fl/fl , Smad3 fl/fl , Smad2/3 fl/fl , and Tgfbr1/2 fl/fl targeted mice (Figure 2A).”
InfluentialSelf-citation
Cited by
Items 501–600 of 925
Chen, J., Pei, Y., Wang, Q., Li, C., Liang, W. Y., & Yu, J. X. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003430 · Cited by 12
“TGF-b is a cytokine secreted by immune cells, cardiac fibroblasts, and cardiomyocytes that induce trans-differentiation of cardiac fibroblasts and matrix collagen deposition [29].”
BackgroundYe, G., Jiao, Y., Deng, L., Cheng, M.-J., Wang, S., Zhang, J., Ouyang, J., Li, Y. H., He, Y., Tu, Z., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.86214 · Cited by 14
“To block the TGF-β signaling in vivo, genetic ablation of Tgfbr2 is more commonly used than genetic depletion of Tgfbr1, Smad2, and Smad3 [21-23], indicating that TGFBR2 inhibition may have a stronger ability to suppress the TGF-β signaling.”
Erythropoietin Alleviates Burn-induced Muscle Wasting
Wu, S., Lu, I., Tai, M., Chai, C., Kwan, A., & Huang, S. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.38590 · Cited by 13
“Smad2/3 and CTGF are the downstream mediators associated with TGF-β-induced fibrosis [90-93].”
BackgroundThe Cell Surface Receptors Ror1/2 Control Cardiac Myofibroblast Differentiation
Chavkin, N. W., Sano, S., Wang, Y., Oshima, K., Ogawa, H., Horitani, K., Sano, M., MacLauchlan, S., Nelson, A. R., Setia, K., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.019904 · Cited by 12
Wang, H., Wu, T., Hua, F., Sun, J., Bai, Y., Wang, W., Liu, J., & Zhang, M. (2022) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-021-00425-1 · Cited by 12
“TGF-b is a master cytokine associated with fibroblast activation [27].”
BackgroundHu, H., Ma, J., Li, Z., Ding, Z., Chen, W., Peng, Y., Tao, Z., Chen, L., Luo, M., Wang, C., et al. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111614 · Cited by 12
Wang, J., Liu, X., Zhuang, Q., Pan, R., Zou, L., Cen, Z., & Tang, L. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.9891 · Cited by 14
“Among these, growth factors are the most widely studied mediators implicated in cardiac fibrosis, including transforming growth factor β (TGF β ) and platelet‑derived growth factor (3).”
Stochastic allelic expression as trigger for contractile imbalance in hypertrophic cardiomyopathy
Montag, J., & Kraft, T. (2020) · Biophysical Reviews · doi:10.1007/s12551-020-00719-z · Cited by 13
Delaunay, M., Paterek, A., Gautschi, I., Scherler, G., & Diviani, D. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2024.119674 · Cited by 12
Tian, J., Li, W., Zeng, L., Yang, L. H., Du, J., Li, Y., Li, B., & Su, G. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18238 · Cited by 11
“By Western blotting, we found that AngII increased the expression of p-smad2/3 in CFs, and the expression of p-smad3 was decreased after HBI-8000 treat-ment, while p-smad2 was not significantly changed (Figure S3B).”
BackgroundMiglustat ameliorates isoproterenol-induced cardiac fibrosis via targeting UGCG
Liu, J., Li, W., Jiao, R., Liu, Z., Zhang, T., Chai, D., Meng, L., Yang, Z., Liu, Y., Wu, H., et al. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01093-w · Cited by 12
“The master cytokine TGF-β mediates tissue fibrosis associated with TGF-β-Smad2/3 signaling, which mobilizes Smad2 and Smad3 transcription factors that control fibrosis by promoting gene expression (Khalil et al. 2017).”
Mia, S., Siokatas, G., Sidiropoulou, R., Hoffman, M., Fragkiadakis, K., Markopoulou, E., Elesawy, M., Roy, R., Blair, S., Kuwabara, Y., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102125 · Cited by 16
“31,60,61 Thus, cardiac hypertrophy with PO seems to require both fibroblast activation and induction of CM FGF21 expression.”
Self-citationOxidative Stress in Diabetic Cardiomyopathy: Molecular Mechanisms and Emerging Therapeutic Targets
Capece, U., Nilo, D., Morciano, C., Nilo, R., Spiezia, S., Sircana, M. C., Russo, V., Perrone, M. A., Bonfrate, L., Acierno, C., et al. (2026) · Biomolecules · doi:10.3390/biom16030470 · Cited by 14
“TGF-β signaling mobilizes Smad2 and Smad3 transcription factors, promoting the expression of fibrosis-related genes and contributing to extracellular matrix accumulation [122].”
Transcriptional regulation of cardiac fibroblast phenotypic plasticity
Villar, K. N. B., Liu, X., & Small, E. M. (2022) · Current Opinion in Physiology · doi:10.1016/j.cophys.2022.100556 · Cited by 12
Zhang, Z., Zhang, F., Zhang, M., Xue, H., Fan, L., & Weng, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-30776-9 · Cited by 11
E3 ubiquitin ligase WWP2 as a promising therapeutic target for diverse human diseases
You, S., Xu, J., Guo, Y., Guo, X., Zhang, Y., Zhang, N., Sun, G., & Sun, Y. (2024) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2024.101257 · Cited by 15
Akboua, H., Eghbalzadeh, K., Keser, U., Wahlers, T., & Paunel‐Görgülü, A. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16915 · Cited by 12
Yu, L., Wang, B., Liu, W., Xu, T., Yang, M., Wang, X., Tan, Q., Yang, S., Fan, L., Cheng, M., et al. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.157231 · Cited by 13
Murata, M., Marugame, Y., Morozumi, M., Murata, K., Kumazoe, M., Fujimura, Y., & Tachibana, H. (2023) · Biomedical Reports · doi:10.3892/br.2023.1601 · Cited by 13
“Furthermore, a previous study has revealed that the deletion of TGFBR1 in fibroblasts suppresses fibrosis (35).”
Lobb, D. C., Doviak, H., Brower, G. L., Romito, E., O’Neill, J. W., Smith, S. H., Shuman, J. A., Freels, P. D., Zellars, K. N., Freeburg, L., et al. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000047 · Cited by 11
“A potentially important event is changes in fibroblast phenotype post-MI (Zamilpa et al., 2011; Ma et al., 2013, 2017; Shinde and Frangogiannis, 2014; Khalil et al., 2017; Fu et al., 2018; Wang et al., 2020).”
BackgroundCardiac Fibroblasts Play Pathogenic Roles in Idiopathic Restrictive Cardiomyopathy
Tsuru, H., Ishida, H., Narita, J., Ishii, R., Suginobe, H., Ishii, Y., Wang, R., Kogaki, S., Taira, M., Ueno, T., et al. (2021) · Circulation Journal · doi:10.1253/circj.cj-20-1008 · Cited by 12
Long noncoding RNA ZFAS1 suppresses chondrocytes apoptosis via miR-302d-3p/SMAD2 in osteoarthritis
Li, J., Liu, M., Li, X., Shi, H., & Sun, S. (2021) · Bioscience Biotechnology and Biochemistry · doi:10.1093/bbb/zbab008 · Cited by 10
Abbas, N. A. T., Nafea, O. E., Mohammed, H. O., Samy, W. M., Abdelmageed, A. F., Afifi, R., & Hassan, H. A. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121692 · Cited by 13
Pericardial Fluid of Patients With Coronary Artery Disease Can Drive Fibrosis Via TGF-Beta Pathway
Hassanabad, A. F., Belke, D. D., Gordon, P. M. K., Teng, G., Dundas, J. A., Zarzycki, A. N., Turnbull, J., Deniset, J., & Fedak, P. W. M. (2024) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2024.06.007 · Cited by 12
The role of cyclic adenosine monophosphate (cAMP) in pathophysiology of fibrosis
Harding, S. L., & Cellek, S. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104368 · Cited by 12
Schmidt, A., Schmidt, K., Groß, S., Lu, D., Xiao, K., Neufeldt, D., Cushman, S., Lehmann, N., Thum, S., Pfanne, A., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-07167-3 · Cited by 10
Li, Y., Chen, X., Zhong, P., Xing, Y., & Miao, P. (2025) · BMC Neurology · doi:10.1186/s12883-025-04460-6 · Cited by 10
Whitehurst, K., Chan, V. A., Estes, H. K., Valsaraj, S., Kent, S. D., Sharma, U. M., Chase, R. C., Bhuiyan, M., & Virag, J. A. I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165811 · Cited by 10
“Based on dosages of ephrinA1-Fc and TGF-β previously reported to treat cells in culture [15,34,48,49], the treatment groups were as follows: Control (vehicle), ephrinA1-Fc 0.”
MethodKarkampouna, S., van der Helm, D., Scarpa, M., van Hoek, B., Verspaget, H. W., Goumans, M., Coenraad, M. J., Kruithof, B. P. T., & Julio, M. K. (2021) · Cells · doi:10.3390/cells10123325 · Cited by 11
The crosstalk between parenchymal cells and macrophages: A keeper of tissue homeostasis
Chen, Y., & Tang, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1050188 · Cited by 13
Tan, J., Wei, J., & Lu, H. (2023) · Inflammation · doi:10.1007/s10753-023-01809-2 · Cited by 11
“TGFβ, as a cytokine, promotes MCF activation and extracellular matrix production and plays a key role in cardiac fibrosis [34].”
BackgroundYuan, P., Liu, J., Xiong, S., Yang, L., Guan, J., Dong, G., & Shi, D. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116558 · Cited by 11
Mushtaq, I., Hsieh, T., Chen, Y., Kao, Y., & Chen, Y. (2024) · iScience · doi:10.1016/j.isci.2024.110084 · Cited by 10
Zhang, B., Hou, J., Liu, J., He, J., Gao, Y., Li, G., Ma, T., Lv, X., Li, D., & Yang, W. (2025) · PLoS ONE · doi:10.1371/journal.pone.0310852 · Cited by 13
“The phosphorylation of Smad2/3, a downstream factor of TGF-β 1, induces cardiac fibroblast differentiation in myofibroblasts [41].”
RetractedDiagnostic and Therapeutic Properties of Exosomes in Cardiac Fibrosis
Fan, J., Ren, M., & He, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.931082 · Cited by 10
Song, X., Nie, L., Long, J., Zhao, J., Liu, X., Wang, L., Liu, D., Wang, S., Liu, S., & Yang, J. (2022) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2023.27.1.1 · Cited by 10
“SMAD family member 2 (Smad2), a receptor of TGF-β1, is the main molecule in the signal transduction pathway that mediates myocardial fibrosis [9,10].”
BackgroundDeacetylase‐dependent and ‐independent role of HDAC3 in cardiomyopathy
Ren, J., Zeng, Q., Wu, H., Liu, X., Guida, M. C., Huang, W., Zhai, Y., Li, J., Ocorr, K. A., Bodmer, R., et al. (2023) · Journal of Cellular Physiology · doi:10.1002/jcp.30957 · Cited by 10
Hu, Y., Qu, H., & Zhou, H. (2023) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207326666230413091715 · Cited by 10
Samidurai, A., Saravanan, M., Ockaili, R. A., Kraskauskas, D., Lau, S. Y. V., Kodali, V., Ramasamy, S., Bhoopathi, K., Nair, M., Roh, S. K., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108998 · Cited by 11
Huang, X., Kang, Y., Jiang, X., Yang, J., Wu, A., Chuanqing, Z., Qin, D., Cao, S., Mei, Q., Ye, Y., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110073 · Cited by 10
Propolis compound inhibits profibrotic TGF-β1/SMAD signalling in human fibroblasts
Randall, L. J., Bajan, S., Tran, T. D., Harvey, R. J., & Russell, F. D. (2025) · Scientific Reports · doi:10.1038/s41598-025-07918-2 · Cited by 9
“5F), COL3A1 in NAHDFs (5.4-fold, Fig.”
InfluentialResearch progress on macrophages in cardiovascular diseases
Zhu, M., Zhou, H., Zhou, L., Yang, Y., & Chen, R. (2025) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-025-03541-4 · Cited by 11
“Through pathways such as TGF-β/Smad3 and Galectin-3, they stimulate cardiac fibroblasts, causing excessive extracellular matrix buildup and myocardial fibrosis [84].”
MicroRNA: unveiling novel mechanistic and theranostic pathways in diabetic cardiomyopathy
De, A., Sarkar, A., Banerjee, T., Bhowmik, R., Sar, S., Shaharyar, M. A., Karmakar, S., & Ghosh, N. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1613844 · Cited by 9
The Adipokine Axis in Heart Failure: Linking Obesity, Sarcopenia and Cardiac Dysfunction in HFpEF
Komić, L., Komic, J., Pavlović, N., Kumrić, M., Bukić, J., Tomić, I. J., & Božić, J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020612 · Cited by 11
Metformin Inhibits the Expression of Biomarkers of Fibrosis of EPCs In Vitro
Han, F., Shu, J., Wang, S., Tang, C., & Luo, F. (2019) · Stem Cells International · doi:10.1155/2019/9019648 · Cited by 9
“In the process of fibrosis, the tissue can express high-level fibrogenic markers [22], such as α-SMA, Col I, Col III, CTGF, and MMP1.”
BackgroundMethodInfluentialYa, H., Wu, A., Lou, L., Zhang, D., Nie, B., Zhao, Y., Liu, K., Zhao, M., & Shang, H. (2019) · Cardiology Research and Practice · doi:10.1155/2019/3786024 · Cited by 9
“TGFβ can initiate noncanonical signal transduction and activate MAPK cascade, eventually activating p38, JNK1/2 signaling pathways [17].”
BackgroundPrognostic value of small mother against decapentaplegic expression in human gastric cancer
Zhang, H., Guo, Y., Sun, L., Ni, F., & Xu, K. (2021) · Bioengineered · doi:10.1080/21655979.2021.1935192 · Cited by 9
“Therefore, HER2 can be used to diagnose all gastric cancer [26].”
BackgroundLi, J., Li, S., Wang, Y., & Shang, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-13254-6 · Cited by 12
Nelson, A. R., Bugg, D., Davis, J., & Saucerman, J. J. (2023) · iScience · doi:10.1016/j.isci.2023.106502 · Cited by 9
Trends in worldwide research on cardiac fibrosis over the period 1989–2022: a bibliometric study
Mao, Y., Fu, Q., Feng, S., Zhang, W., Zhong, Z., Zhou, Y., & Yang, C. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1182606 · Cited by 12
“(215 citations) (79), as well as another high-quality review concerning cell biological processes, molecular mechanisms, and therapeutic opportunities of cardiac fibrosis written by Prof.”
BackgroundWang, X., Liu, X., Xu, L., Li, Y., Zheng, B., Xia, C., Wang, J., & Liu, H. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112483 · Cited by 9
Maimaitijiang, A., Huang, Q., Wu, Y., Sun, S., & Chen, Q. (2024) · CytoJournal · doi:10.25259/cytojournal_32_2024 · Cited by 9
Jia, Y., Chang, Y., Sun, P., Li, H., & Guo, Z. (2020) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2020.105733 · Cited by 9
Antifibrotic Effects of (−)-Epicatechin on High Glucose Stimulated Cardiac Fibroblasts
Garate‐Carrillo, A., Ramírez‐Sánchez, I., Nguyen, J. P., Gonzalez, J., Ceballos, G. M., & Villarreal, F. J. (2021) · Journal of Medicinal Food · doi:10.1089/jmf.2020.0210 · Cited by 9
Trott, A. J., Greenwell, B. J., Karhadkar, T. R., Guerrero‐Vargas, N. N., Escobar, C., Buijs, R. M., & Menet, J. S. (2022) · BMC Biology · doi:10.1186/s12915-022-01256-9 · Cited by 9
Intermedin1–53 Inhibits NLRP3 Inflammasome Activation by Targeting IRE1α in Cardiac Fibrosis
Zhang, L., Zhang, J., Hou, Y.-L., Lu, W., Ni, X.-Q., Lin, F., Liu, X., Wang, X., Yu, Y.-R., Jia, M.-Z., et al. (2022) · Inflammation · doi:10.1007/s10753-022-01642-z · Cited by 9
Bao, H., Li, X., Lai, X., Chen, X., Li, Y., Yao, Z., Huang, Z., Huang, J., Chang, L., & Zhang, G. (2022) · Inflammation Research · doi:10.1007/s00011-022-01634-7 · Cited by 10
“TGF-β is recognized as an important player in the fibrotic process through activating the Smad2/3 pathway [14, 26, 42].”
BackgroundZhang, M., Xinzhou, W., Chen, W., Liu, W., Xin, J., Yang, D., Zhang, Z., & Zheng, X. (2023) · Scientific Reports · doi:10.1038/s41598-023-36117-0 · Cited by 9
Pathogenic Roles of Cardiac Fibroblasts in Pediatric Dilated Cardiomyopathy
Tsuru, H., Yoshihara, C., Suginobe, H., Matsumoto, M., Ishii, Y., Narita, J., Ishii, R., Wang, R., Ueyama, A., Ueda, K., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.029676 · Cited by 9
“15,16 Animal models mimicking myocardial infarction or hypertensive cardiac diseases have revealed that CFs play various roles in the damaged heart 16– 18 ; however, their specific function in cardiomyopathy remains unclear.”
Zhao, Q., Yang, W., Li, X., Yuan, H., Guo, J., Wang, Y., & Shan, Z. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08755-0 · Cited by 9
“The canonical TGF-β/Smad2/3 signalling pathways plays a key role in the formation of cardiac fibrosis [17, 31].”
BackgroundVishnyakova, P., Gantsova, E. A., Киселева, В. В., Lazarev, D. S., Knyazev, E. N., Poltavets, A. S., Iskusnykh, M., Muminova, K., Potapova, A., Сагдуллаевна, Х. З., et al. (2023) · Placenta · doi:10.1016/j.placenta.2023.12.003 · Cited by 9
Trotta, M. C., Herman, H., Ciceu, A., Mladin, B., Roșu, M., Lepre, C. C., Russo, M., Bácskay, I., Fenyvesi, F., Marfella, R., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1332212 · Cited by 9
Ski drives an acute increase in MMP-9 gene expression and release in primary cardiac myofibroblasts
Landry, N. M., Kavosh, M., Filomeno, K. L., Rattan, S. G., Czubryt, M. P., & Dixon, I. (2018) · Physiological Reports · doi:10.14814/phy2.13897 · Cited by 11
Yousefi, F., Soltani, B. M., & Rabbani, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-82226-z · Cited by 10
Dai, C., Cao, Y., Huang, F., & Wang, Y. (2022) · World Journal of Stem Cells · doi:10.4252/wjsc.v14.i1.41 · Cited by 11
Epigenetic Regulation of Heart Failure: Cell Type Matters
Padula, S. L., & Yutzey, K. E. (2021) · Circulation Research · doi:10.1161/circresaha.121.319642 · Cited by 9
Perreault, L. R., Daley, M. C., Watson, M. C., Rastogi, S., Jaiganesh, A., Porter, E. C., Duffy, B. M., & Black, L. D. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1279932 · Cited by 10
Search progress of pyruvate kinase M2 (PKM2) in organ fibrosis
Lv, S., Cao, M., Luo, J., Fu, K., & Yuan, W. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09307-w · Cited by 8
“In this context, Smad2/3 acts as a transcriptional activator of TGF-β, promoting the activation of cardiac fibroblasts into myofi - broblasts and exacerbating pathological CF [ 73 ].”
The Macrophage–Fibroblast Dipole in the Context of Cardiac Repair and Fibrosis
Psarras, S. (2024) · Biomolecules · doi:10.3390/biom14111403 · Cited by 9
Tan, Q., Zhou, M., You, X., Ma, J., Ye, Z., Shi, W., Cui, X., Mu, G., Yu, L., & Chen, W. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.177380 · Cited by 8
The impact of aging and biological sex on cardiac collagen metabolism
Pandya, K., Menendez, A., MacAskill, M. G., Gray, G. A., & Tavares, A. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112079 · Cited by 9
“Synthesis is primarily regulated by the transforming growth factor β (TGF-β ) signalling pathway, which drives fibroblast-to-myofibroblasts differentiation and ECM protein production during fibrosis (Khalil et al., 2017).”
Lactate and lactylation: mechanisms, function, diseases, and therapeutic targets
Wang, X., Liu, C., Chen, Y., Fang, Y., Li, J. N., Liu, Y., Pan, Y., Bao, S., Wang, X., Liu, Y., et al. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00472-x · Cited by 10
“Following myocardial infarction, monocytes rely on high glycolytic flux to supply lactate, which promotes the expression of lactylation-modified repair genes such as Lrg1, Vegf-a, and IL-10, facilitating anti-inflammatory responses and angiogenesis [111, 112].”
Chen, R., Huang, L., Zheng, W., Zhang, M., Xin, Z., Liu, L., & Chen, Z. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.105106 · Cited by 8
Wang, K., Zhou, M., Zhang, Y., Jin, Y., Xue, Y., Mao, D., & Rui, Y.-J. (2024) · Biomaterials Science · doi:10.1039/d3bm01665j · Cited by 8
Liu, F., Chen, Y., Qin, D., & Cheng, Q. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155256 · Cited by 8
Patil, M., Singh, S., Dubey, P. K., Tousif, S., Umbarkar, P., Zhang, Q., Lal, H., Sewell-Loftin, M. K., Umeshappa, C. S., Ghebre, Y. T., et al. (2024) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2024.03.004 · Cited by 9
Zhang, M., Sun, X., Zhao, F., Chen, Z., Liu, M., Wang, P., Lu, P., & Wang, X. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118980 · Cited by 9
Zhang, J., Lei, Y., Li, R., He, Y., & Chen, Z. (2025) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-025-10678-z · Cited by 8
Dopamine receptor 3: A mystery at the heart of cardiac fibrosis
Byrne, S. E., Vishwakarma, N., Sriramula, S., & Katwa, L. C. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120918 · Cited by 8
Repair of Limb Ischemia Is Dependent on Hematopoietic Stem Cell Specific-SHP-1 Regulation of TGF-β1
Wang, C., Nistala, R., Cao, M., Li, D., Pan, Y., Golzy, M., Cui, Y., Liu, Z., & Kang, X. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.122.318205 · Cited by 9
Niu, Y., Sun, Y., Liu, Y., Du, K., Xu, X., & Ding, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044106 · Cited by 8
“The TGF-β signaling pathway represents another molecular event implicated in pathogenesis, most notably in the induction of myocardial fibrosis in ACM [75,76].”
BackgroundSamuelsson, A., Bartolomaeus, T. U. P., Anandakumar, H., Thowsen, I., Nikpey, E., Han, J., Markó, L., Finne, K., Tenstad, O., Eckstein, J., et al. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad040 · Cited by 8
Chen, Z., Chen, X., Zhu, B., Yu, H., Bao, X., Hou, Y., Song, W., Sun, S., & Li, Z. (2023) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00052 · Cited by 8
Niu, P., Tan, X., Zhou, X., Xu, X., Guannan, Z., Li, P., & Bai, M. (2023) · Food Bioscience · doi:10.1016/j.fbio.2023.103157 · Cited by 8
Li, Z., Kosgei, V. J., Bison, A., Alberto, J., Umoret, R., Maskali, F., Brunaud, L., Guéant, J., & Guéant‐Rodriguez, R. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202100065 · Cited by 9
Santos, G. L., DeGrave, A. N., Rehman, A., Disi, S. A., Xhaxho, K., Schröder, H., Bao, G., Meyer, T., Tiburcy, M., Dworatzek, E., et al. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.213041 · Cited by 10
Novel molecular therapeutic targets in cardiac fibrosis: a brief overview
Wang, R., Lin, J. J., & Bagchi, R. A. (2018) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2018-0430 · Cited by 8
“The transcription factor Smad family member 3 (Smad3) has a well-known pro-fibrotic role; it is activated by TGF-β (Khalil et al. 2017) and appears to upregulate extracellular matrix production via a synergistic interaction with another novel transcription factor, scleraxis (Bagchi and Czubryt 2012).”
BackgroundDrugging transcription in heart failure
Padmanabhan, A., & Haldar, S. M. (2019) · The Journal of Physiology · doi:10.1113/jp276745 · Cited by 9
“…contractile dysfunction and pathological cardiac remodelling, many of which may originate within non-myocyte cell types (Kanisicak et al. 2016; Khalil et al. 2017; Molkentin et al. 2017; Fu et al. 2018; Honold & Nahrendorf, 2018; Nahrendorf, 2018; Swirski & Nahrendorf, 2018; Valiente-Alandi…”
BackgroundEffect of dietary fat and sucrose consumption on cardiac fibrosis in mice and rhesus monkeys
Natarajan, N., Vujić, A., Das, J., Wang, A. C., Phu, K. K., Kiehm, S., Ricci-Blair, E. M., Zhu, A. Y., Vaughan, K. L., Colman, R. J., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.128685 · Cited by 11
GSK2593074A blocks progression of existing abdominal aortic dilation
Khoury, M. K., Zhou, T., Yang, H. M., Prince, S. R., Gupta, K., Stranz, A., Wang, Q., & Liu, B. (2020) · JVS Vascular Science · doi:10.1016/j.jvssci.2020.07.001 · Cited by 8
The Cardiac Myofibroblast: From Supporting Cast to Leading Role?
Alexanian, M., & Haldar, S. M. (2018) · Circulation Research · doi:10.1161/circresaha.118.314185 · Cited by 8
A Macrophage‐Based Cell Therapy Approach Promotes Collagen Deposition in Diabetic Wounds
Boodhoo, K., Vlok, M., & van de Vyver, M. (2025) · Wound Repair and Regeneration · doi:10.1111/wrr.70071 · Cited by 7
“TGFβ-activation of fibroblasts induces differentiation into myofibroblasts that secrete ECM proteins and is thought to drive fibrosis through Smad-dependent signalling pathways [34–37].”
ANTXR1 blockade enhances cardiac function in preclinical models of heart failure
Boccella, N., Yu, G., Seaman, S., Feng, Y., Lee, J., Tomassoni‐Ardori, F., Yang, L., Hsu, K.-S., Dunleavey, J. M., Becker, J., et al. (2025) · Nature Cardiovascular Research · doi:10.1038/s44161-025-00725-y · Cited by 8
Nie, W., Yan, J., Xie, Z., Liu, Y., Zhang, J., Wang, Y., Wang, Z., & Zhao, Z. (2026) · BIO Integration · doi:10.15212/bioi-2025-0159 · Cited by 8
Xie, H., Shen, X., Zhao, N., Ye, P., Ge, Z., & Hu, Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.696635 · Cited by 8
“CFs and the progression of fibrogenesis (Bansal et al., 2017; Khalil et al., 2017).”
Schaefer, A., Kiss, A., Oszwald, A., Nagel, F., Acar, E., Aliabadi-Zuckermann, A., Hackl, M., Zuckermann, A. O., Kain, R., Jakubowski, A., et al. (2022) · Transplant International · doi:10.3389/ti.2022.10057 · Cited by 7
Paar, V., Haslinger, M., Krombholz-Reindl, P., Pittner, S., Neuner, M., Jirak, P., Kolbitsch, T., Minnich, B., Schroedl, F., Kaser-Eichberger, A., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1264216 · Cited by 7
Baba, Y., Maezawa, Y., Kondo, N., Minamizuka, T., Udagawa, H., Ide, S., Ide, K., Teramoto, N., Yamaguchi, A., Kaneko, H., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-13102-3 · Cited by 7
Sulaiman, A., Chambers, J., Chilumula, S. C., Vinod, V., Kandunuri, R., McGarry, S., & Kim, S. H. (2022) · Cancers · doi:10.3390/cancers14061577 · Cited by 8
Wu, S., He, R.-L., Zhao, L., Yu, X., Jiang, Y.-N., Guan, X., Chen, Q.-Y., Ren, F.-F., Xie, Z.-Y., Wu, L., et al. (2022) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2022.10.005 · Cited by 7
Metadata
- Authors
- Khalil, H., Kanisicak, O., Prasad, V., Correll, R. N., Fu, X., Schips, T., Vagnozzi, R. J., Liu, R., Huynh, T., Lee, S.-J., Karch, J., & Molkentin, J. D.
- Affiliations
- Cincinnati Children's Hospital Medical Center (US)
- Johns Hopkins University (US)
- Corresponding author
- Molkentin, Jeffery D.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2017-09-11
- Volume
- 127
- Issue
- 10
- Pages
- 3770-3783
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC5617658
- OpenAlex
- W2750808153
- Cited by
- 905
- References
- 64
- Citations by year
- 2026: 92 · 2025: 102 · 2024: 128 · 2023: 121 · 2022: 144 · 2021: 110 · 2020: 84 · 2019: 85 · 2018: 34 · 2017: 2
- FWCI
- 43.33
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Civil War Book Review (submittedVersion)
- Language arts journal of Michigan (submittedVersion)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (158486, 148429)
- National Institutes of Health
- National Heart, Lung, and Blood Institute (P01HL069779, R01HL105924)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR060636)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Keywords
- myocardial fibrosis, TGF-beta signaling, Smad2, Smad3, cardiac fibroblasts, myofibroblasts, TGF-beta receptor, pressure overload, cardiac hypertrophy, extracellular matrix remodeling
- MeSH terms
- Receptor, Transforming Growth Factor-beta Type I, Receptor, Transforming Growth Factor-beta Type II, Animals, Fibrosis, Heart Diseases, Male, Mice, Transgenic, Myocardium, Organ Specificity, Signal Transduction, Transforming Growth Factor beta, Protein Serine-Threonine Kinases, Gene Deletion, Receptors, Transforming Growth Factor beta, Myocytes, Cardiac, Mice, Smad2 Protein, Smad3 Protein, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.